Severe Asthma - New InsightsA WAO Symposium presented during the WAO International Scientific Conference (WISC 2016) in Jerusalem, Israel (8 December 2016).
University of Southampton
Hadassa Hebrew University Medical Center
Severe Asthma Phenotypes and Fungal Allergic Respiratory Disease
Aspirin Exacerbated Respiratory Disease
Tel-Aviv Sourasky Medical Center
Novel Therapies for Severe-Unresponsive Asthma
Brigham and Women’s Hospital
This symposium is an activity of the WAO Collaboration on Severe Asthma.
For support through independent education grants, WAO thanks Teva Pharmaceuticals, founding supporter, and Sanofi Genzyme and Regeneron Pharmaceuticals.